| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Environmental Toxicology Graduate Program (K.S.), Department of Cell Biology and Neuroscience (V.M., V.P., F.M.S.), Cell, Molecular and Developmental Biology Graduate Program (K.C.), University of California, Riverside, California 92521; Center for Cell Signaling (B.M.P.), Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia 22908; Département de Biologie et Génomique Structurales (Y.B., D.M.), Institut de Génétique et de Biologie Moléculaire et Cellulaire, 67404 Illkirch, France; and Division of Pulmonary Biology (Y.M.), Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio 45229
Address all correspondence and requests for reprints to: Dr. Frances M. Sladek, Department of Cell Biology and Neuroscience, 2115 Biological Sciences Building, University of California, Riverside, California 92521-0314. E-mail: frances.sladek{at}ucr.edu.
Nuclear receptors (NRs) are a superfamily of transcription factors whose genomic functions are known to be activated by lipophilic ligands, but little is known about how to deactivate them or how to turn on their nongenomic functions. One obvious mechanism is to alter the nuclear localization of the receptors. Here, we show that protein kinase C (PKC) phosphorylates a highly conserved serine (Ser) between the two zinc fingers of the DNA binding domain of orphan receptor hepatocyte nuclear factor 4
(HNF4
). This Ser (S78) is adjacent to several positively charged residues (Arg or Lys), which we show here are involved in nuclear localization of HNF4
and are conserved in nearly all other NRs, along with the Ser/threonine (Thr). A phosphomimetic mutant of HNF4
(S78D) reduced DNA binding, transactivation ability, and protein stability. It also impaired nuclear localization, an effect that was greatly enhanced in the MODY1 mutant Q268X. Treatment of the hepatocellular carcinoma cell line HepG2 with PKC activator phorbol 12-myristate 13-acetate also resulted in increased cytoplasmic localization of HNF4
as well as decreased endogenous HNF4
protein levels in a proteasome-dependent fashion. We also show that PKC phosphorylates the DNA binding domain of other NRs (retinoic acid receptor
, retinoid X receptor
, and thyroid hormone receptor ß) and that phosphomimetic mutants of the same Ser/Thr result in cytoplasmic localization of retinoid X receptor
and peroxisome proliferator-activated receptor
. Thus, phosphorylation of this conserved Ser between the two zinc fingers may be a common mechanism for regulating the function of NRs.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
P. Lu, G. B. Rha, M. Melikishvili, G. Wu, B. C. Adkins, M. G. Fried, and Y.-I. Chi Structural Basis of Natural Promoter Recognition by a Unique Nuclear Receptor, HNF4{alpha}: DIABETES GENE PRODUCT J. Biol. Chem., November 28, 2008; 283(48): 33685 - 33697. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gineste, A. Sirvent, R. Paumelle, S. Helleboid, A. Aquilina, R. Darteil, D. W. Hum, J.-C. Fruchart, and B. Staels Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity Mol. Endocrinol., November 1, 2008; 22(11): 2433 - 2447. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Ponguta, C. W. Gregory, F. S. French, and E. M. Wilson Site-specific Androgen Receptor Serine Phosphorylation Linked to Epidermal Growth Factor-dependent Growth of Castration-recurrent Prostate Cancer J. Biol. Chem., July 25, 2008; 283(30): 20989 - 21001. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Hwang-Verslues and F. M. Sladek Nuclear Receptor Hepatocyte Nuclear Factor 4{alpha}1 Competes with Oncoprotein c-Myc for Control of the p21/WAF1 Promoter Mol. Endocrinol., January 1, 2008; 22(1): 78 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang and R. L. Klemke PhosphoBlast, a Computational Tool for Comparing Phosphoprotein Signatures among Large Datasets Mol. Cell. Proteomics, January 1, 2008; 7(1): 145 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ponugoti, S. Fang, and J. K. Kemper Functional Interaction of Hepatic Nuclear Factor-4 and Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator 1{alpha} in CYP7A1 Regulation Is Inhibited by a Key Lipogenic Activator, Sterol Regulatory Element-Binding Protein-1c Mol. Endocrinol., November 1, 2007; 21(11): 2698 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Buchanan, C. Ricciardelli, J. M. Harris, J. Prescott, Z. C.-L. Yu, L. Jia, L. M. Butler, V. R. Marshall, H. I. Scher, W. L. Gerald, et al. Control of Androgen Receptor Signaling in Prostate Cancer by the Cochaperone Small Glutamine Rich Tetratricopeptide Repeat Containing Protein {alpha} Cancer Res., October 15, 2007; 67(20): 10087 - 10096. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |